Koyfin Home > Directory > Health Care > Ampio Pharmaceuticals > Capital Expenditures

Ampio Pharmaceuticals Capital Expenditures Chart (AMPE)

Ampio Pharmaceuticals annual/quarterly Capital Expenditures from 2010 to 2018.
  • Ampio Pharmaceuticals Capital Expenditures for the quarter ending September 09, 2018 was $0m a 10.59% decrease of 0m year over year
  • Ampio Pharmaceuticals Capital Expenditures for the last 12 months ending September 09, 2018 was $-1m a 86.22% decrease of 0m year over year
  • Ampio Pharmaceuticals Annual Capital Expenditures for 2017 was $0m a 90.54% decrease of 0m from 2016
  • Ampio Pharmaceuticals Annual Capital Expenditures for 2016 was $0m a -1,514.48% increase of 0m from 2015
  • Ampio Pharmaceuticals Annual Capital Expenditures for 2015 was $0m a -7,745.02% increase of 9m from 2014
Other Cash Flow Metrics:
  • Ampio Pharmaceuticals Cash Flow from Operations for the quarter ending September 09, 2018 was $-3m a 19.89% decrease of -1m year over year
  • Ampio Pharmaceuticals Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-3m a 68.32% decrease of -2m year over year
  • Ampio Pharmaceuticals Total Revenue for the quarter ending December 12, 2015 was $0m a 95.43% increase of 0m year over year
View Chart On Koyfin

Quarterly AMPE Capital Expenditures Data

09/2018$0m
06/2018$0m
03/2018$0m
12/2017$0m
09/2017$0m
03/2017$0m
12/2016$0m
12/2015$0m
09/2015$0m
06/2015$0m

Annual AMPE Capital Expenditures Data

2017$0m
2016$0m
2015$0m
2014$-9m
2013$-1m
2011$0m